Joint EMA/EORTC Workshop

Amsterdam, NL (Hybrid Event)

The European Medicines Agency (EMA) and the European Organisation for Research and Treatment of Cancer (EORTC) are jointly organising a workshop called “How can patient-reported outcomes (PRO) and health-related quality of life (HRQoL) data inform regulatory decisions?

This workshop will bring together international experts from academia, learned societies, patients, regulatory agencies, health technology assessment bodies, and industry.

Date: Thursday, 29 February 2024
Location: European Medicines Agency, Amsterdam

Next events

  • 24th Workshop on Methods in Clinical Cancer Research (MCCR)

    Sint Michielgestel, Netherlands

  • CDDF Live Webinar: Cancer Medicines Forum

    Virtual Event

  • HTx proton therapy case study workshop

    Brussels, Belgium (hybrid)

  • EORTC Melanoma Group Autumn Meeting 2024

    Barcelona, Spain

  • CDDF-EORTC Workshop on Innovation and Access in Rare Cancers

    Amsterdam, NL (Hybrid Event)